# HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE
> **ANDA088017** · Abbreviated New Drug Application (Generic) · Sponsor: ACTAVIS MID ATLANTIC · Approved 1983-07-05
## Drug
- **FDA Application Number:** ANDA088017
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE
- **Generic name:** HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE
- **Active ingredients:** HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE
- **Dosage form:** SYRUP
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ACTAVIS MID ATLANTIC
- **Manufacturer:** Actavis Pharma, Inc.
- **First approval:** 1983-07-05
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=088017)
---
*MORVS · CC0 1.0*